Related Experiment Video
Updated: May 9, 2026
08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction
Michael Madigan1, Brian Zuckerbraun
1University of Pittsburgh , Pittsburgh, PA , USA.
Frontiers in Immunology
|July 13, 2013
Summary
The nitrate/nitrite/nitric oxide (NO) pathway offers therapeutic potential for vascular dysfunction. This alternative NO generation route may overcome issues like endothelial nitric oxide synthase (eNOS) uncoupling and arginase competition.
Area of Science:
- Vascular Biology
- Biochemistry
- Pharmacology
Background:
- Endothelial nitric oxide synthase (eNOS) generates nitric oxide (NO) from L-arginine, regulating vascular tone.
- Dysregulation of the L-arginine/eNOS pathway is linked to vascular diseases like atherosclerosis and pulmonary hypertension.
- Reduced NO bioavailability, due to arginase competition and eNOS uncoupling, contributes to vascular pathology.
Purpose of the Study:
- To review the therapeutic potential of the nitrate/nitrite/NO pathway.
- To explore this pathway as an alternative source of NO in vascular dysfunction.
Main Methods:
- Literature review of studies on the nitrate/nitrite/NO pathway.
- Analysis of mechanisms underlying NO generation from nitrate and nitrite.
- Evaluation of evidence for therapeutic applications in vascular diseases.
Main Results:
- The nitrate/nitrite/NO pathway provides an alternative route for NO generation.
- This pathway may bypass L-arginine competition and eNOS uncoupling.
- Evidence suggests potential benefits in various vascular conditions.
Conclusions:
- The nitrate/nitrite/NO pathway represents a promising therapeutic strategy.
- Increasing NO bioavailability via this route could treat vascular dysfunction.
- Further research is warranted to fully elucidate its clinical applications.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:202° Amines to N-Nitrosamines: Reaction with NaNO2
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.